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Osteoporosis and Its Relationship with
Various Risk Factors in Postmenopausal
Women in Denizli Province
ABS TRACT Ob jec ti ve: Os te o po ro sis is an im por tant cli ni cal con di ti on fre qu ently se en in post me no pa u -
sal wo men. It is the ma jor ca u se of ver teb rael and hip frac tu res. The in ci den ce of os te o po ro tic frac tu res
has be en in cre a sing and half of the el derly fe ma le po pu la ti on in most Wes tern as well as Asi an co un tri es
has been af fec ted. The aim of this study was to de ter mi ne the post me no pa u sal os te o po ro sis ra te and eva l-
u a te the re la ti ons hip bet we en os te o po ro sis and va ri o us risk fac tors in post me no pa u sal wo men li ving in the
cen tral and ru ral are as of De niz li. Ma te ri al and Met hods: Sub jects we re se lec ted ran domly among post me -
no pa u sal wo men who we re en rol led in Vil la ge He alth Cen ters of De niz li Pro vin ci al Di rec to ra te of ,He -
alth by pub lic an no un ce ments. We eva lu a ted 1100 post me no pa u sal wo men out of 16113 wo men, aged
45-80 ye ars. The bo ne mi ne ral den sity of the pa ti ents was me a su red by qu an ti ta ti ve ul tra so und of the ti -
bia. Sub jects with T sco res lo wer than -2.5 SD we re di ag no sed as os te o po ro sis ac cor ding to the World He -
alth Or ga ni za ti on cri te ri a. Re sults: The ra tes of os te o po ro sis in va ri o us are as ranged between 19.8% and
53.9% (me an 36.8%). The sub jects we re di vi ded in to two gro ups as with os te o po ro sis and wit ho ut os te o -
po ro sis. Ave ra ge me narc he age was gre a ter in the os te o po ro tic gro up. The sub jects who had ta ken hor mo -
ne rep la ce ment the rapy (HRT) had lo wer os te o po ro sis ra te. Sub jects with os te o po ro sis had lo wer exer ci se
sco re and had lack of sun ex po su re du e to co ve ring. A po si ti ve cor re la ti on was fo und bet we en os te o po ro -
sis age and the du ra ti on of me no pa u se. Conc lu si on: We fo und that the in ci den ce of os te o po ro sis among
post me no pa u sal wo men was very high es pe ci ally in ru ral are as of De niz li. Age, du ra ti on of me no pa u se,
age of me narc he and mul ti pa rity ap pe ared to be im por tant risk fac tors in de ve lop ment of os te o po ro sis. Ho -
we ver, HRT, physi cal ac ti vity and sun ex po su re could pre vent os te o po ro sis. Un ders tan ding the epi de mi -
o logy and frac tu re risk of os te o po ro sis may ul ti ma tely aid in re du cing the pub lic he alth bur den of this
com mon di sor der.
Key Words: Os te o po ro sis; post me no pa u se; risk fac tors    
ÖZET Amaç: Os te o po roz post me no po zal ka dın lar da sık gö rü len önem li bir kli nik du rum dur. Ver teb ra ve
kal ça kı rık la rı nın baş lı ca ne de ni dir. Os te o po ro tik kı rık la rın sık lı ğı art mak ta dır ve ço ğu Ba tı ül ke sin de ve
As ya ül ke le rin de ki yaş lı ka dın nü fu su nun ya rı sı et ki len mek te dir. Bu ça lış ma nın ama cı De niz li’ nin mer -
ke zin de ki ve kır sal ke si min de ki post me no po zal ka dın lar da post me no po zal os te o po roz ora nı nı sap ta mak
ve os te o po roz la çe şit li risk fak tör le ri ara sın da ki iliş ki yi de ğer len dir mek ti. Ge reç ve Yön tem ler: Ol gu lar hal -
ka ya pı lan du yu ruy la De niz li’ de ki Sağ lık Ba kan lı ğı İl Sağ lık Mü dür lü ğü’ ne bağ lı sağ lık ocak la rın da ka yıt -
lı post me no po zal ka dın lar ara sın dan rast ge le se çil di. Yaş la rı 45-80 ara sın da olan 16113 ka dın dan 1100
post me no po zal ka dı nı de ğer len dir dik. Has ta la rın ke mik mi ne ral yo ğun luk la rı ti bi a nın kan ti ta tif ul tra so -
nu ile öl çül dü. Dün ya Sağ lık Ör gü tü kri ter le ri ne go re T sko ru -2.5 stan dart sap ma nın al tın da olan has ta -
la ra os te o po roz ta nı sı ko nul du. Bul gu lar: Çe şit li böl ge ler de os te o po roz ora nı %19.8 ile %53.9 ara sın da
de ği şi yor du (or ta la ma %36.8). Ol gu lar os te o po ro zu olan lar ve ol ma yan lar ol mak üze re iki gru ba ay rıl dı.
Os te o po ro zu olan grup ta me narş ya şı da ha bü yük tü. Hor mo ne rep las man te da vi si (HRT) alan lar da os te -
o po roz ora nı da ha dü şük tü. Os te o po ro zu olan la rın eg zer siz sko ru da ha dü şük tü ve ör tün me ye bağ lı ola -
rak gü ne şe ma ru zi yet le ri az dı. Os te o po roz ya şı ile me no poz sü re si ara sın da po zi tif ko re las yon bu lun du.
So nuç: Özel lik le De niz li’ nin kır sal böl ge sin de ki post me no po zal ka dın lar da os te o po roz sık lı ğı nın çok yük -
sek ol du ğu nu bul duk. Yaş, me no poz sü re si, me narş ya şı ve mul ti par ti te os te o po roz ge li şi min de önem li
risk fak tör le ri ola rak gö rül mek te dir. Fa kat HRT, fi zik sel ak ti vi te ve gü ne şe ma ruz kal mak os te o po ro zu
ön le ye bi lir. Os te o po ro zun epi de mi yo lo ji si nin ve kı rık ris ki nin an la şıl ma sı bu yay gın  has ta lı ğın halk sağ -
lı ğı na ge tir di ği yü kün azal tıl ma sı na yar dım cı ola bi lir.
Anah tar Ke li me ler: Os te o po roz; post me no poz; risk fak tör le ri      
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steoporosis is a common disease that may
lead to serious disability, increased mor-
bidity and mortality, and significant
health-care costs.1 It is also the major cause of ver-
tebrael and hip fractures. The incidence of osteo-
porotic fractures has been increasing and half of the
elderly female populations in most Western as well
as Asian countries has been affected.2 Approxi-
mately, 30-50 percent of postmenopausal women
are estimated to have osteoporosis.3,4 Dual-energy
X-ray absorptiometry (DXA) is an accurate and
precise method of determining bone mineral den-
sity (BMD), and has been used mainly for the di-
agnosis of osteopenia and osteoporosis for
ascertaining fracture risk and monitoring the treat-
ment.5 Recently, quantitative ultrasound (QUS) has
been proposed as a reliable alternative method for
evaluating osteoporosis and fracture risk. It may be
useful for measuring both the quality and quantity
of bone and many studies demonstrated its ability
to determine the fracture risk, independent of age
and BMD.6,7 This study was carried out in post-
menopausal women living in the central and rural
areas of Denizli province, in Western Anatolia Re-
gion of Turkey. Our aim was to determine the in-
cidence of postmenopausal osteoporosis and
evaluate its relationship with various risk factors.
MATERIAL AND METHODS
Provincial Directorate of Health (PDH) was in-
formed about the design of this study. Because the
approval of PDH was granted, we did not apply for
further Research Council approval. This popula-
tion-based cross-sectional study was conducted
under the supervision of a researcher from Pa-
mukkale University Medical Faculty, after the ap-
proval of PDH. Public announcements were made
by PHD to collect subjects from 13 villages of
Denizli. There were 16113 postmenopausal
women enrolled in Village Health Centers (VHC)
in as much as last census. Finally, 1100 post-
menopausal women aged 45-80 years were in-
cluded in the study from within the subjects who
applied after the announcement and accepted to
participate. All participants gave their written in-
formed consent.
All subjects completed an interviewer-admin-
istered risk factor questionnaire, which contained
sections on cigarette smoking, alcohol and caffeine
consumption. Their physical activity was also eval-
uated by the information about the occupation,
work and leisure-time activities. The history of
medical problems and medications known to affect
bone mineral density including diabetes mellitus,
obesity, thyrotoxicosis, anorexia, connective tissue
diseases, neoplasms, immobilization history (longer
than two months), use of corticosteroids more than
three months, thyroid hormone, phenytoine and
hormone replacement therapy (HRT) for 12 months
or more were excluded. Although more than 3 cm
height loss is another risk factor,8 we did not evalu-
ate this, because heights of these subjects were not
measured previously. Additionally, the cases who
used antiresorptive drugs for osteoporosis and those
with type 1 diabetes mellitus were excluded.
Body weight (Wt) was measured, (after re-
moval of shoes and heavy outdoor clothings) using
a balance beam scale. Height (Ht) was measured
(after removal of shoes) using a Filizola stadiome-
ter. Height and weight were used to calculate the
body mass index (BMI, as kg/m2). The age, age at
menarche and menopause, years since menopause,
parity condition, history of fracture and fracture
history in the family were recorded. All cases were
evaluated for back pain and the exposure to the sun
(because women living in rural areas of Denizli
generally covered due to religion and traditions).
BMD measurement was carried out by means of
QUS of the tibia. Speed of sound (SOS, meters per
second) was determined at the right tibia using the
Sound Scan 2000 (Myriad Ultrasound Systems, Is-
rael; version 1.20 and 1.30 BETA). The standard
measurement size was defined as the mid-point be-
tween the apex of the malleolus and the distal
patellar apex. The probe was moved manually
across the mid-tibial plane, parallel to the long axis
of the tibia, searching for the site with maximal
SOS reading, lasting about 5-10 minutes. The aver-
age of the five highest readings was considered as
the representative result.7,9 Data were analyzed and
expressed as SOS and T score. Although there has
been no consensus on the T score cut-offs and di-
agnostic categories to be used with QUS, the in-
strument used commonly in Turkey also accepts
the World Health Organization (WHO) criteria as
cut-off values. Subjects with a T score lower than-
2.5 SD were diagnosed as osteoporosis.10
Diagnostic laboratory investigations (for hy-
perthyroidism, diabetes mellitus, rheumatoid
arthritis or others) were not carried out in this
study. Additionally, diagnostic compatibility be-
tween QUS and DXA was not investigated.
The statistical analyses were performed Statis-
tical Package for the Social Sciences version 16
(SPSS 16, Chicago, IL, USA). The differences be-
tween both groups were analyzed by Pearson’s
Chi-square test and Student’s t-test where appro-
priate and followed by multiple logistic regression
models with all potential risk factors. We used
one-way ANOVA test to assess differences among
more than two groups. Correlations were analyzed
by Pearson’s correlation test. All results were ex-
pressed as the mean ± SD, and P values smaller than
0.05 were considered as statistically significant.
RESULTS
The rates of osteoporosis in the center and various
rural areas of Denizli in Western Anatolia ranged
between 19.8% and 53.9% (mean 36.8%, popula-
tion-adjusted prevalence 33.6%) (Table 1). The rate
of osteoporosis increases with age whereas SOS val-
ues decreased with age (Table 2).
The subjects were divided into two groups as
osteoporotic (group I) and non-osteoporotic (group
II) groups. The clinical data of the cases are shown
in Table 3.
Menopause age, fracture history, fracture his-
tory in the family, caffeine intake, adequate 
calcium intake, smoking, diabetes mellitus, hyper-
thyroidism, and drug use were not found statisti-
cally significantly different between group I and II
(Table 3, and 4).
When cases were divided into two groups ac-
cording to BMI, osteoporosis rate was found as
28.9% in cases with BMI >30 kg/m2 while this rate
was 30.6% in cases with BMI <30 kg/m2; however
this difference was not significant. The complaint
of back pain was more frequent in group I than
group II. We also evaluated various risk factors in
both groups (Table 4).
A positive correlation was found between os-
teoporosis and age (r= 0.33, p< 0.001) and duration
of menopause ( r= 0.34; p< 0.001). There was a neg-
ative correlation between SOS and age (r= -0.41; p<
0.001) and duration of menopause (r= -0.44; p<
0.001). Similarly a negative correlation was found
between T score and age (r= -0.35; p< 0.001), and
the duration of menopause ( r= -0.39; p< 0.001).
The ratios for fracture history and parents’
fracture history were not significantly different be-
tween group I and II. On the other hand, the SOS
values of the cases with facture history was signif-
icantly lower than the cases with no facture his-
tory (3541 ± 429 m/s vs. 3617 ± 311 m/s, p< 0.01,
respectively).
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TABLE 1: The frequency of osteoporosis in the center
and various rural areas of Denizli (center of Denizli had
lower osteoporosis rate than rural areas, p< 0.001).
Age groups Osteoporosis rate SOS (m/s)
45-54 7.2 3742 ± 413
55-64 39 3608 ± 359
65-74 48.1 3584 ± 308
75+ 66.7 3403 ± 345
TABLE 2: The rate of osteoporosis in postmenopausal
women and the SOS values according to the age
groups, (p< 0.001).
SOS: Speed of sound.
The SOS values (r= 0.32; p< 0.001) and T score
(r= 0.30; p< 0.001) were positively correlated with
physical activity. A strong relationship was found
between osteoporosis and lower levels of physical
activity (χ2= 25.327; SD= 1; p< 0.001) and HRT (χ2=
40.91; SD= 1; p< 0.005). Additionally, multiparity
was negatively correlated with T score (r= -0.20; p<
0.001) and SOS values (r= -0.18; p< 0.001). There
was no correlation between osteoporosis and BMI.
Moreover, in multiple logistic regression analysis, a
high activity level, sun exposure and HRT were
found as significant factors that prevent osteoporo-
sis (Table 5).
DISCUSSION
According to WHO 30% of postmenopausal white
women could be affected by osteoporosis.10 In the
present study, the proportion of osteoporosis in
postmenopausal women ranged between 19.8%
and 53.9% (mean 36.8%). 
The QUS may be used for first-line public os-
teoporosis screening and it may be accepted as a
valid and practical method.11,12
Fracture risk not only depends-on BMD, but
also other factors such as bone turnover rate, bone
architecture and geometry etc.13,14 Therefore,
WHO developed a fracture risk assessment tool
(FRAX®) recently. It is a computer-based algorithm
that provides models for the assessment of fracture
risk in men and women to estimatea 10-year-
fracture probability. The data used to estimate frac-
ture risk in this tool are age, sex, weight, height,
previous fracture, parents’ hip fracture history,
smoking, use of corticosteroids, presence of
rheumatoid arthritis, secondary osteoporosis (type
1 diabetes, hyperthyroidism, hypogonadism, mal-
nutrition or malabsorption and chronic liver dis-
ease), alcohol consumption and BMD.15 The FRAX
tool Turkey results may be incorrect probably due
to insufficient data.13 In this paper, we also evalu-
ated other risk factors such as menarche age, daily
activity status, sunlight exposure, suffering from
back-pain, and type 2 diabetes mellitus.
It is not surprising that there is no uniform en-
tity as diabetic osteopathy due to the different
pathogenesis of diabetes mellitus type 1 and type
2.16 Type 1 diabetes mellitus is characterized with
absolute insulin deficiency and was previously
called as insulin dependent diabetes mellitus, and
insulin has anabolic effect on the tissues. Type 1 di-
abetes is a disease of youngsters and occasionally
occurrs after 2nd decade of life [which called latent
autoimmune diabetes of adults (LADA)]. We ex-
cluded patients with type 1 diabetes due to pres-
ence of chronic end-organ complications and a
small number of cases. Patients with type 2 dia-
betes mellitus display an increased fracture risk de-
spite a higher BMD which is mainly attributable to
the increased risk of falling.17 In our study, type 2
diabetes ratio among cases with osteoporosis was
not statistically different when compared to the
cases without osteoporosis. 
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Parameters Group I (n= 349) Group II  (n= 751) p value
Age (yrs) 61.5 ± 8.6 55.3 ± 8.1 <0.001
Weight (kg) 67.6 ± 12.5 68.6 ± 12.1 ns
BMI (kg/m2) 28.3 ± 4.4 28.3 ± 4.5 ns
Menopause age (yrs) 44.4 ± 6 45.6 ± 6.6 ns
Duration of menopause (yrs) 16.9 ± 9.9 9.2 ± 9.7 <0.001
Age at menarche (yrs) 14.7 ± 1.8 14.3 ± 1.5 <0.01
Back pain rate (%) 73.4 55.4 <0.001
TABLE 3: The clinical data in Group I and group II 
(ns: not significant).
Risk factors Group I Group II p value
Parity condition 4.6 ± 2.8 4.1 ± 2.3 <0.05
Fracture history (%) 4.6 3.8 ns
Fracture history in family (%) 10 11 ns
HRT (%) 2.9 7.3 <0.05
Caffeine intake 4.5 3.6 ns
Adequate calcium intake (%) 85.5 90.1 ns
Smoking (%) 2.6 1.8 ns
Diabetes mellitus (%) 10.4 13.1 ns
Hyperthyroidism (%) 1.7 3 ns
Drug usage (%) 2.6 2.1 ns
Adequate activity (%) 35.3 59.8 <0.001
Adequate sun exposure (%) 4.6 21.9 <0.001
TABLE 4: Comparison of the various risk factors 
in groups I and II.
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Previous studies showed that age and
menopausal status were important risk factors for
osteoporosis, and were strongly associated with
fracture risk in older women.18-20 Our findings are
in accordance with the age and menopausal status
of previous studies. In the present study, osteo-
porosis rate increases with age, and there is a strong
correlation between osteoporosis and the duration
of menopause. 
The majority of the cross-sectional studies on
age at menarche and premenopausal bone health
suggest an inverse relationship between two. Some
of the studies demonstrated a relationship between
spinal bone density and age of menarche, and
women with normal bone mineral density (BMD)
had experienced menarche significantly earlier
than women with lower mineral density.21,22 In
contrast, some studies found no significant rela-
tionship between menarche age and bone mass.23-26
In our study, age of menarche was significantly
older in osteoporotic group. These different results
may be explained with different criteria used for
case selection (e.g. age ranges of cases that affect
menopausal status and rate of osteoporosis were not
equal among different studies) as a result of differ-
ent study designs and including more subjects into
the study when compared to other studies.
The results of studies that investigated the ef-
fect of parity on osteoporosis in both pre- and post-
menopausal women are also inconsistent. Recent
hip fracture studies found that multiparous (more
than four children) women were at a higher risk
than women with one or two children.27,28 Our
findings indicate that multiparous women are at
higher risk for osteoporosis. This may be explained
by the inadequate calcium intake during pregnancy
and breastfeeding.29
Weight is consistently associated with positive
measurements of BMD in normal premenopausal
and obese women.30,31 BMI has been studied less,
however it also demonstrates a consistent positive
relationship with bone mineral measurement.32,33
In two prospective studies of obese and pre- and
postmenopausal women, BMD decreased dramati-
cally with weight loss and was regained with sub-
sequent weight gain.34-36 In our study, osteoporosis
rate was found to lower in obese individuals, how-
ever the difference with the nonobese cases was
not statistically significant. Some cross-sectional
studies reported that physical activity was posi-
tively related with BMD,35-37 but other studies did
not confirm this finding.38-40 Walking and aerobic
exercise were associated with high BMD when
compared to sedentary controls.41 Our cases had no
regular exercise, however regular physical activity
was lower in osteoporotic group than in non-os-
teoporotic group.
Caffeine intake increases urinary calcium ex-
cretion for at least three hours after consumption
and it has been associated with some evidence of
altered bone remodeling process.42,43 In an obser-
vational study, daily consumption of caffeine
equivalent to 2-3 cups of coffee was associated with
accelerated bone mineral loss from the spine and
total body in postmenopausal women who con-
sumed less than 744 mg calcium/day.44 Another
study reported a small but significant negative re-
lationship between caffeine intake and calcium bal-
ance that was no longer significant after adjusting
for calcium intake.45 We found that caffeine intake
95% confidence interval (CI) for Exp (B)
B Standard Error (SE) Wald df p Exp (B) Lower upper
Sun exposure 1.5059 0.2796 29.0057 1 <0.001 4.5083 2.6062 7.7986
Activity 0.8598 0.1406 37.3751 1 <0.001 2.3627 1.7935 3.1127
HRT 0.8680 0.3673 5.5851 1 0.018 2.3821 1.1597 4.8930
Back pain -0.4868 0.1537 10.0329 1 0.002 0.6146 0.4547 0.8306
Constant -3.2082 0.4426 52.5329 1 <0.001
TABLE 5: Independent variables related to osteoporosis as in logistic regression model.
-2 log likelihood ratio: 1246,100.
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was similar in both groups. Women living in rural
areas do frequently consume coffee in our country
as a tradition. 
Smoking has an increasing cumulative nega-
tive effect on BMD. BMD decreases approximately
2% per decade after menopause in female smok-
ers.46 Because Turkish women living in rural areas
generally do not smoke, the rate of smoking was
very low in our cases. 
Reports concerning the effects of alcohol on
BMD yielded conflicting results. Although some
studies found no association between alcohol con-
sumption and BMD,47 some others observed a sig-
nificant inverse association.48 Excess alcohol intake
appears to have a modest adverse effect on the
preservation of bone mass, mainly by suppressing
bone formation.49 However none of the cases in this
study consumed alcohol. For that reason, we could
not evaluate the relationship between osteoporosis
and alcohol consumption.
To our knowledge, it is known that hormone
replacement therapy (HRT) prevents the reduction
of bone density related to the postmenopausal hy-
poestrogenism. It was recently reported that low-
dose oral contraceptive administration was able to
prevent perimenopausal decrease in radial and ver-
tebral BMD.50-52 Similarly, we found that subjects
who were on HRT had lower osteoporosis rate re-
gardless of oral or transdermal use.
The lack of calcium intake is one of the impor-
tant risk factors for osteoporosis. Conversely, an in-
crease in calcium intake decreases the activation
frequency of osteoclasts.53 Intervention studies in-
dicated that calcium supplementation of approxi-
mately 1000 mg/day can prevent premenopausal
bone mineral loss at all clinically relevant skeletal
sites.54,55 Recent reviews also concluded that ade-
quate or supplemental calcium intake reduced bone
mineral loss in premenopausal women.56,57 In our
cases, calcium intake was similar in both groups.
Therefore, there may be other factors that affect the
absorption and excretion of calcium such as dietary
fiber, protein and sodium intake, irregular and in-
sufficient calcium intake or vitamin D insuffi-
ciency.58 In fact, our cases were not administered
vitamin D in addition to calcium, and they had lack
of sun exposure due to traditional and religious cov-
ering.
Although the SOS values of the cases with
fracture history were lower than the ones without
fracture history, significant difference was not
found between group I and II. This may be ex-
plained by the other fracture risks as bone geome-
try, etc., apart from low bone mineral density.
The difference of osteoporosis rate between
central and rural areas may be explained with ge-
netic predisposition as a result of frequent consan-
guineous marriages, less medical care, low income
and education levels, however, this issue is open to
discussion because we did not evaluated these data. 
CONCLUSION
In accordance with the literature, our study indi-
cates that the incidence of osteoporosis is very high
in postmenopausal population especially in the
rural areas of Denizli. It must be emphasized that
age, duration of menopause, age of menarche, and
multiparity appear as important risk factors in de-
velopment of osteoporosis. In contrast, HRT, phys-
ical activity and sun exposure are able to prevent
osteoporosis. QUS is a reliable and easy alternative
method for screening of osteoporosis. In addition,
another main advantage of QUS examination is
alosence of any radiation exposure and the low cost
of the equipment. Understanding the epidemiology
and fracture risk of osteoporosis may ultimately aid
in reducing the public health burden of this com-
mon disease. Additionally, fracture a risk assess-
ment tool (FRAX®) for Turkish people may be
developed after new comprehensive studies.
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